THE STUDY OF FLOMOXEF IN THE PEDIATRIC FIELD

Flomoxef (FMOX; 6315-S), a new synthetic oxacephem antibiotic, was studied in the pediatric field and pharmacokinetic and clinical results obtained were summarized below. 1. The activity of FMOX against Staphylococcus aureus isolated from clinical patients, including latamoxef resistant strains was...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1987, Vol.40(8), pp.1349-1363
Hauptverfasser:	SATO, HAJIME, NARITA, AKIRA, NAKAZAWA, SHINICHI, SUZUKI, HIROYUKI, MASTUMOTO, KIMIKO, NAKANISHI, YOSHIKO, NAKAZAWA, SUSUMU, NIINO, KENJI, NAKADA, YOSHIO
Format:	Artikel
Sprache:	jpn
Schlagworte:	Age Factors Bacteria - drug effects Bacterial Infections - microbiology Cephalosporins - pharmacokinetics Cephalosporins - pharmacology Cephalosporins - therapeutic use Child Child, Preschool Drug Evaluation Drug Resistance, Microbial Female Humans Infant Male Respiratory Tract Infections - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Flomoxef (FMOX; 6315-S), a new synthetic oxacephem antibiotic, was studied in the pediatric field and pharmacokinetic and clinical results obtained were summarized below. 1. The activity of FMOX against Staphylococcus aureus isolated from clinical patients, including latamoxef resistant strains was very high and MIC was approximately
ISSN:	0368-2781 2186-5477
DOI:	10.11553/antibiotics1968b.40.1349